Medical research

Turkey holds Phase 3 trials for local vaccine candidate

Turkey has begun to administer its national COVID-19 vaccine candidate, TURKOVAC, on volunteers in Istanbul as part of Phase 3 trials.

Jointly developed by the Health Ministry, Health Institutes of Turkey (TUSEB) and Erciyes University, the national inactive candidate vaccine is being administered at the Başakşehir Çam and Sakura City Hospital ahead of wider use.

Bosnia Entity’s Secrecy Over Vaccine Procurement Draws Criticism

A woman receives a dose of the COVID-19 vaccine. Photo: EPA-EFE/ANTONIO BAT.

Following the signing of the contract for direct procurement of 500,000 doses with Chinese vaccine Sinopharm on June 10, BIRN BiH journalists filed a request for free access to information, seeking a copy of the contract.

Official Gheorghita: By getting vaccinated we are protected from the Delta variant

The anti-COVID vaccine also offers protection against the Delta variant, and without increasing the vaccination rate it will be very difficult to avoid later an increase in the number of SARS-CoV-2 virus infections, the head of the National Committee for the Coordination of Vaccination Activities against COVID-19, Valeriu Gheorghita, stated on Wednesday.

Turkey administers over 52.3 mln vaccine jabs to date

Turkey has administered over 52.34 million doses of COVID-19 vaccines since it launched a mass vaccination campaign in January, according to official figures released on July 3.

More than 35.78 million people have received their first doses, while over 15.58 million have been fully vaccinated, the Health Ministry said.

Turkey administers over 50.75 mln coronavirus vaccine shots

Turkey has administered over 50.75 million doses of COVID-19 vaccines since it launched a mass vaccination campaign in January, according to official figures released on July 1. 

More than 35.15 million people have received their first doses, while over 15.25 million have been fully vaccinated, the Health Ministry said.

Pages